Effective drug therapy for vitreoretinal disease is a major challenge in the field of
ophthalmology; various protective systems, including anatomical and physiological barriers …

Non-infectious uveitis (NIU) is a disorder with various etiologies and is characterized by eye
inflammation, mainly affecting people of working age. An accurate diagnosis of NIU is crucial …

Noninfective uveitis is a major cause of vision impairment, and corticosteroid medication is a
mainstay clinical strategy that causes severe side effects. Rapamycin (RAPA), a potent …

Glaucoma and uveitis are non-vascular ocular diseases which are among the leading
causes of blindness and visual loss. These conditions have distinct characteristics and …

Non-infectious uveitis, an ocular inflammatory condition that affects the iris, ciliary body,
choroid, and adjacent tissues (retina, optic nerve, and vitreous), is an important cause of …

Purpose: The aim of this study was to elucidate the effect of itaconate (ITA) on experimental
autoimmune uveitis (EAU), to explore its potential mechanism, and to identify potential …

Objective To study the clinical characteristics and long-term outcomes of patients with
noninfectious uveitis (NIU) who are treated with systemic immunomodulatory therapy (IMT) …

Background: Although infliximab has been recommended for the second-line treatment of
seronegative spondyloarthropathy-or juvenile idiopathic arthritis-related uveitis, the issue of …

Background: To compare the efficacy and safety of advanced intravitreal therapeutic
regimens, including a dexamethasone implant at 350 and 700 μg; a fluocinolone acetonide …

One of the main immune-mediated diseases that lead to avoidable blindness is non-
infectious uveitis. Glucocorticoids are the first-line therapy choice for noninfectious uveitis; …